{"prompt": "['MK-7902', 'PAGE 3', 'PROTOCOL NO.007-05 (E7080-G000-314)', 'Supplemental SAP', '15JUL2021', '3.6.4.', 'Demographic and Baseline Characteristics', '23', '3.7.', 'Interim Analyses', '23', '3.7.1.', 'Efficacy Interim Analysis', '24', '3.7.2.', 'Safety Interim Analyses', '25', '3.8.', 'Multiplicity', '25', '3.8.1.', 'Objective Response Rate', '26', '3.8.2.', 'Progression-free Survival', '26', '3.8.3.', 'Overall Survival', '27', '3.8.4.', 'Safety Analyses', '29', '3.9.', 'Sample Size and Power Calculations', '29', '3.10.', 'Subgroup Analyses', '30', '3.11.', 'Compliance (Medication Adherence)', '30', '3.12.', 'Extent of Exposure', '30', '4.', 'STATISTICAL ANALYSIS PLAN FOR EXTENSION', '31', '4.1.', 'Introduction', '31', '4.2.', 'Responsibility for Analyses/In-House Blinding', '31', '4.3.', 'Hypotheses/Estimation', '31', '4.4.', 'The Analysis Enppoints', '32', '4.4.1.', 'Efficacy Enppoints', '32', '4.4.1.1.', 'Primary Enppoints', '32', '4.4.1.2.', 'Secondary Enppoints', '32', '4.4.1.3.', 'Exploratory Enppoints', '32', '4.4.2.', 'Safety Enppoints', '32', '4.4.3.', 'Patient-reported Outcome Enppoints', '32', '4.5.', 'Analysis Populations', '33', '4.5.1.', 'Efficacy Analysis Populations', '33', '4.5.2.', 'Safety Analysis Populations', '33', '4.5.3.', 'Patient-reported Outcome Analysis Population', '33', '4.5.4.', 'Pharmacokinetic Analysis Population', '34', '4.6.', 'Statistical Methods', '34', '4.6.1.', 'Statistical Methods for Efficacy Analyses', '34', '4.6.1.1.', 'Progression-free Survival', '34', '4.6.1.2.', 'Overall Survival', '35', 'C', 'Confidential']['MK-7902', 'PAGE 4', 'PROTOCOL NO.007-05 (E7080-G000-314)', 'Supplemental SAP', '15JUL2021', '4.6.1.3.', 'Objective Response Rate', '35', '4.6.1.4.', 'Duration of Response', '35', '4.6.2.', 'Statistical Methods for Safety Analyses', '36', '4.6.3.', 'Statistical Methods for PRO Analysis', '36', '4.6.4.', 'Summaries of Baseline Characteristics, Demographics, and Other Analyses', '36', '4.7.', 'Interim Analysis and Final analysis', '36', '4.8.', 'Multiplicity', '36', '4.9.', 'Sample Size and Power Calculations', '36', '5. APPENDICES:', '37', '5.1.', 'Rules for Non-Binding Futility Analyses', '37', '5.2. ABBREVIATIONS', '39', '6.', 'REFERENCES', '42', 'C', 'Confidential']\n\n###\n\n", "completion": "END"}